Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up.

S-A KimH MoonJong-Lyel RohS-B KimS-H ChoiS Y NamS Y Kim

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2017)

Our data show that β-blocker use is associated with decreased survival and calcium-channel blockers is associated with increased cancer recurrence in patients of HNSCC.

Keyphrases

angiotensin converting enzyme
end stage renal disease
free survival
ejection fraction
chronic kidney disease
newly diagnosed
blood pressure
papillary thyroid
prognostic factors
cardiovascular events
peritoneal dialysis
coronary artery disease
big data
risk factors